Alpha IVF Group Berhad (KLSE:ALPHA)

Market Cap	1.36B -9.8%
Revenue (ttm)	190.00M +9.4%
Net Income	55.25M -3.2%
EPS	0.01 -4.9%
Shares Out	4.86B
PE Ratio	24.68
Forward PE	22.40
Dividend	0.01 (3.51%)
Ex-Dividend Date	Mar 18, 2026

Volume	483,200
Average Volume	2,341,985
Open	0.2850
Previous Close	0.2850
Day's Range	0.2800 - 0.2850
52-Week Range	0.2550 - 0.3450
Beta	0.50
RSI	56.67
Earnings Date	Apr 22, 2026

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation op...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2011
• Employees: 198
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: ALPHA

Financial Performance

In fiscal year 2025, Alpha IVF Group Berhad's revenue was 176.84 million, an increase of 5.52% compared to the previous year's 167.59 million. Earnings were 57.45 million, an increase of 8.54%.